Secret to a long life cheaper than you think celebrity physician Peter Attia reveals

Don't miss Dr Peter Attia who will speak at the Sohn Hearts & Minds Conference at the Sydney Opera House next month.

Jared Lynch

Secret to a long life cheaper than you think celebrity physician Peter Attia reveals

October 6, 2023
Don't miss Dr Peter Attia who will speak at the Sohn Hearts & Minds Conference at the Sydney Opera House next month.
Read Transcript

It was a TV show meant to promote longevity. But soon after Chris Hemsworth appeared with celebrity physician Peter Attia on Disney+ documentary series Limitless, it seemed to have cut short the actor’s career.

Headlines around the world screamed that the movie star, who has built his career on playing the Marvel superhero Thor, was taking a break from acting after it was revealed during the series that he had a genetic predisposition to Alzheimer’s disease.

Turns out the revelation that he carried two copies of the APOE4 gene - which has been linked to an increased risk of developing degenerative brain disorder - and his impending absence from movie screens, was a coincidence or conflated at the very least.

“I don’t think I’m sharing anything that Chris wouldn’t be comfortable sharing,” Dr Attia, 50, tells The Weekend Australian.

“I know Chris wasn’t taking time off because of that knowledge (that he carried the APOE4 gene). Chris was taking time off because Chris was exhausted. Chris has worked insanely hard for a decade - never not working on a project.‍

“And I think that was taking a toll on him. Regardless of what his genetic predisposition was to Alzheimer’s disease, Limitless provided a great opportunity for Chris to say ‘OK, I really do need to take a little bit of a break’ - even the production of Limitless was far more taxing than it was ever billed to any of us. In Chris’s case, he was able to take some time to recharge with his family.”

And this encapsulates Dr Attia’s main piece of advice when people ask him what is the secret to living longer.

The fountain of youth and keys to a long life has been pursued for a millennia. It’s as old as man. It’s the question centenarians get asked when they are propped up in their easy chair on their big day and get peppered with questions about how they have reached such a grand age, with their answers as varied as their years.

“I think you see why every interview with a centenarian trying to elucidate the cause of or drivers of their lifespan produces some of the most comical responses,” Dr Attia says.‍

“It could be more cigars, more cigarettes, more whiskey, more family, more commitment - it‘s a random generator of responses.”

The Sohn Hearts & Minds conference will be held at the Sydney Opera House on November 17.

But according to Dr Attia - who will speak at the Sohn Hearts & Minds in Sydney next month - nothing is completely random. He has built a career unearthing about what fuels a long life and shared his knowledge in the bestselling book Outlive: The Science & Art of Longevity.

And what creates a long life is less complex and less expensive than it appears. In fact, if you followed it literally, it would send you off to sleep.

Embracing boredom, is Dr Attia’s main piece of advice. It appears to fly in the face of Bob Dylan’s wisdom of a man who is “not busy being born is busy dying”. But being bored, surprisingly, has significant health benefits.

 

“I will say that it is probably the single hardest thing for high achieving people to do. And it‘s a discomfort that is almost unimaginable,” Dr Attia says.

“I think boredom is a very important thing. I think it‘s very healthy for us to be bored and Mother Nature/natural selection has hard wired us to not want to spend much time in that situation.

“And ironically, it might be more important today than it was 100,000 years ago. You could argue maybe 100,000 years ago, it wasn’t that important and that’s why natural selection made it so uncomfortable. But today, the world we live in could not have been anticipated by Darwin, and by Darwin I don’t mean the actual person of course, I mean, the forces of natural selection. And that’s I think exactly why in this hyperstimulating world, we all need a way to be bored.”

Dr Attia is highlighting the need to be able to switch off and rest - a tough task in the modern ‘always on’ era, where extreme business has become the norm. People can communicate like never before - receiving on average more than hundreds of notifications a day via text messages, social media alerts, emails advertising and more. It’s creating digital overload that is a main cause of flatlining productivity as more employees become burnt out.

“We need a way to be in nature,” Dr Attia says while speaking to The Weekend Australian on a video call.

“I mean, think about it, the fact that I‘m looking at you on a screen from inside an air conditioned room with perfect right angles everywhere, this can’t be really healthy for my nervous system.

“It‘s healthy for me in many ways, and I wouldn’t trade this for anything - I don’t want to be living outdoors, fending off lions and tigers. But I gave something up when I adopted this lifestyle and I think it’s important that we all spend time outdoors every single day, we all spend time in the asymmetry of nature. We all spend time looking at sunlight, we all spend time being uncomfortable in extreme temperatures.”

Peter Attia says we all need to find more time to spend outdoors.

While the Sohn Hearts & Minds conference will include rapid-fire stock picks from leading investment experts all over the globe, all of the events’ profits go to medical research with organisers targeting to raise $60m by next month.

Dr Attia labels his longevity research as medicine 3.0. He says there needs to be a shift from treating disease to preventing it in the first place, with longevity not just about reaching a ripe old age - but also living with a higher quality and more active life for longer.

“What I call medicine. 3.0 is really geared towards that degree of prevention. It‘s how do you live longer without atherosclerosis? How do you slow the progression of those things? And that’s probably where, you know, we won’t necessarily all get to be centenarians, I have no expectation that I will be given my genes, but I definitely think it adds years to life. And I think more importantly, it adds quality to life.

“To focus more on, ‘hey, when I‘m 80, how can I physically and cognitively function, the way I see a healthy 65 year old today?’ Boy, that has more bearing on the quality of your life than anything else because, you know, lifespan without healthspan is a curse.

“In fact most people are quite afraid of that. Nobody wants to live a long life and be suffering.

“So I think that what we really ought to be doing is focusing on healthspan focusing on what does the final decade of my life look like physically, cognitively, emotionally. Those are the three things that are going to define the quality of your life. And if I make sure that my actions today are setting me up, to have the best version of that final decade, what I call the marginal decade, then not only will that be exceptional, but everything leading up to it will be as well.”

And despite healthcare costs rising and the global dietary supplements market generating billions of dollars a year, Dr Attia says money can’t buy good health.

“The most expensive aspect is time. I mean, for most people to make the changes that would have the biggest impact on the length and quality of their life. Exercising every single day, eating reasonably well - yeah, that‘s going to cost a little bit more money. But it’s going to cost more time.

“It‘s good news in the sense that it’s the great equaliser. It’s bad news in that you can’t really cheat and cram for the test. You know, you can’t just say, ‘well, look, I’m willing to pay a premium for this, so therefore, I’m going to have a better experience’. I mean, it doesn’t really work that way.

“There are very, very wealthy people who have incredibly poor health. That there and then tells you, you can‘t really buy health. You can’t. On average, certainly poor socioeconomic status is associated with worse health. But at the individual level, that’s completely untrue - that’s evidenced by the fact that some of the richest people in the world are some of the least healthy.”

This article was originally posted by The Australian here.

Licensed by Copyright Agency. You must not copy this work without permission.

Disclaimer: This material has been prepared by Australian, published on 6 October 2023. HM1 is not responsible for the content of linked websites or content prepared by third party. The inclusion of these links and third-party content does not in any way imply any form of endorsement by HM1 of the products or services provided by persons or organisations who are responsible for the linked websites and third-party content. This information is for general information only and does not consider the objectives, financial situation or needs of any person. Before making an investment decision, you should read the relevant disclosure document (if appropriate) and seek professional advice to determine whether the investment and information is suitable for you.

It was a TV show meant to promote longevity. But soon after Chris Hemsworth appeared with celebrity physician Peter Attia on Disney+ documentary series Limitless, it seemed to have cut short the actor’s career.

Headlines around the world screamed that the movie star, who has built his career on playing the Marvel superhero Thor, was taking a break from acting after it was revealed during the series that he had a genetic predisposition to Alzheimer’s disease.

Turns out the revelation that he carried two copies of the APOE4 gene - which has been linked to an increased risk of developing degenerative brain disorder - and his impending absence from movie screens, was a coincidence or conflated at the very least.

“I don’t think I’m sharing anything that Chris wouldn’t be comfortable sharing,” Dr Attia, 50, tells The Weekend Australian.

“I know Chris wasn’t taking time off because of that knowledge (that he carried the APOE4 gene). Chris was taking time off because Chris was exhausted. Chris has worked insanely hard for a decade - never not working on a project.‍

“And I think that was taking a toll on him. Regardless of what his genetic predisposition was to Alzheimer’s disease, Limitless provided a great opportunity for Chris to say ‘OK, I really do need to take a little bit of a break’ - even the production of Limitless was far more taxing than it was ever billed to any of us. In Chris’s case, he was able to take some time to recharge with his family.”

And this encapsulates Dr Attia’s main piece of advice when people ask him what is the secret to living longer.

The fountain of youth and keys to a long life has been pursued for a millennia. It’s as old as man. It’s the question centenarians get asked when they are propped up in their easy chair on their big day and get peppered with questions about how they have reached such a grand age, with their answers as varied as their years.

“I think you see why every interview with a centenarian trying to elucidate the cause of or drivers of their lifespan produces some of the most comical responses,” Dr Attia says.‍

“It could be more cigars, more cigarettes, more whiskey, more family, more commitment - it‘s a random generator of responses.”

The Sohn Hearts & Minds conference will be held at the Sydney Opera House on November 17.

But according to Dr Attia - who will speak at the Sohn Hearts & Minds in Sydney next month - nothing is completely random. He has built a career unearthing about what fuels a long life and shared his knowledge in the bestselling book Outlive: The Science & Art of Longevity.

And what creates a long life is less complex and less expensive than it appears. In fact, if you followed it literally, it would send you off to sleep.

Embracing boredom, is Dr Attia’s main piece of advice. It appears to fly in the face of Bob Dylan’s wisdom of a man who is “not busy being born is busy dying”. But being bored, surprisingly, has significant health benefits.

 

“I will say that it is probably the single hardest thing for high achieving people to do. And it‘s a discomfort that is almost unimaginable,” Dr Attia says.

“I think boredom is a very important thing. I think it‘s very healthy for us to be bored and Mother Nature/natural selection has hard wired us to not want to spend much time in that situation.

“And ironically, it might be more important today than it was 100,000 years ago. You could argue maybe 100,000 years ago, it wasn’t that important and that’s why natural selection made it so uncomfortable. But today, the world we live in could not have been anticipated by Darwin, and by Darwin I don’t mean the actual person of course, I mean, the forces of natural selection. And that’s I think exactly why in this hyperstimulating world, we all need a way to be bored.”

Dr Attia is highlighting the need to be able to switch off and rest - a tough task in the modern ‘always on’ era, where extreme business has become the norm. People can communicate like never before - receiving on average more than hundreds of notifications a day via text messages, social media alerts, emails advertising and more. It’s creating digital overload that is a main cause of flatlining productivity as more employees become burnt out.

“We need a way to be in nature,” Dr Attia says while speaking to The Weekend Australian on a video call.

“I mean, think about it, the fact that I‘m looking at you on a screen from inside an air conditioned room with perfect right angles everywhere, this can’t be really healthy for my nervous system.

“It‘s healthy for me in many ways, and I wouldn’t trade this for anything - I don’t want to be living outdoors, fending off lions and tigers. But I gave something up when I adopted this lifestyle and I think it’s important that we all spend time outdoors every single day, we all spend time in the asymmetry of nature. We all spend time looking at sunlight, we all spend time being uncomfortable in extreme temperatures.”

Peter Attia says we all need to find more time to spend outdoors.

While the Sohn Hearts & Minds conference will include rapid-fire stock picks from leading investment experts all over the globe, all of the events’ profits go to medical research with organisers targeting to raise $60m by next month.

Dr Attia labels his longevity research as medicine 3.0. He says there needs to be a shift from treating disease to preventing it in the first place, with longevity not just about reaching a ripe old age - but also living with a higher quality and more active life for longer.

“What I call medicine. 3.0 is really geared towards that degree of prevention. It‘s how do you live longer without atherosclerosis? How do you slow the progression of those things? And that’s probably where, you know, we won’t necessarily all get to be centenarians, I have no expectation that I will be given my genes, but I definitely think it adds years to life. And I think more importantly, it adds quality to life.

“To focus more on, ‘hey, when I‘m 80, how can I physically and cognitively function, the way I see a healthy 65 year old today?’ Boy, that has more bearing on the quality of your life than anything else because, you know, lifespan without healthspan is a curse.

“In fact most people are quite afraid of that. Nobody wants to live a long life and be suffering.

“So I think that what we really ought to be doing is focusing on healthspan focusing on what does the final decade of my life look like physically, cognitively, emotionally. Those are the three things that are going to define the quality of your life. And if I make sure that my actions today are setting me up, to have the best version of that final decade, what I call the marginal decade, then not only will that be exceptional, but everything leading up to it will be as well.”

And despite healthcare costs rising and the global dietary supplements market generating billions of dollars a year, Dr Attia says money can’t buy good health.

“The most expensive aspect is time. I mean, for most people to make the changes that would have the biggest impact on the length and quality of their life. Exercising every single day, eating reasonably well - yeah, that‘s going to cost a little bit more money. But it’s going to cost more time.

“It‘s good news in the sense that it’s the great equaliser. It’s bad news in that you can’t really cheat and cram for the test. You know, you can’t just say, ‘well, look, I’m willing to pay a premium for this, so therefore, I’m going to have a better experience’. I mean, it doesn’t really work that way.

“There are very, very wealthy people who have incredibly poor health. That there and then tells you, you can‘t really buy health. You can’t. On average, certainly poor socioeconomic status is associated with worse health. But at the individual level, that’s completely untrue - that’s evidenced by the fact that some of the richest people in the world are some of the least healthy.”

This article was originally posted by The Australian here.

Licensed by Copyright Agency. You must not copy this work without permission.

Disclaimer: This material has been prepared by Australian, published on 6 October 2023. HM1 is not responsible for the content of linked websites or content prepared by third party. The inclusion of these links and third-party content does not in any way imply any form of endorsement by HM1 of the products or services provided by persons or organisations who are responsible for the linked websites and third-party content. This information is for general information only and does not consider the objectives, financial situation or needs of any person. Before making an investment decision, you should read the relevant disclosure document (if appropriate) and seek professional advice to determine whether the investment and information is suitable for you.

facebook
linkedin
All
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Wellcome Trust chief investment officer Nicholas Moakes. Picture: Steven PocockWellcome Trust chief investment officer Nicholas Moakes. Picture: Steven PocockWellcome Trust chief investment officer Nicholas Moakes. Picture: Steven PocockWellcome Trust chief investment officer Nicholas Moakes. Picture: Steven Pocock
September 5, 2024

Honesty the only policy that matters, says Wellcome Trust’s Nicholas Moakes

The chief investment officer of the London-based $71bn Wellcome Trust, Nick Moakes, has a simple rule for the trust’s investment team: “Never invest with anyone who is or has been or should have been in prison.”

Read More
September 5, 2024

Why Howard Marks says you’re making a big mistake

Howard Marks says investors must ignore manic depressive markets and focus on the bigger picture. Rates will be higher for longer and that will bring pain – and opportunity.

Read More
July 21, 2024

Investors ‘comfortable’ about a Trump presidency, despite volatility

Economists and market experts say the outcome of the US presidential election has been largely priced in by investors as softening inflation helps to buoy sharemarkets both globally and locally.

Read More
Qiao Ma, portfolio manager at Munro Partners, says the Nvidia rally is nowhere close to being over. Picture: Oscar ColmanQiao Ma, portfolio manager at Munro Partners, says the Nvidia rally is nowhere close to being over. Picture: Oscar ColmanQiao Ma, portfolio manager at Munro Partners, says the Nvidia rally is nowhere close to being over. Picture: Oscar ColmanQiao Ma, portfolio manager at Munro Partners, says the Nvidia rally is nowhere close to being over. Picture: Oscar Colman
May 28, 2024

The AI bulls are sticking to Nvidia despite 600pc share price rally

Nvidia’s quarterly earnings once again exceeded analysts’ expectations and Portfolio Manager, Qiao Ma of Munro Partners says the rise is “nowhere close to being over”.

Read More
Munro Partners' Kieran Moore likes US Tex-Mex fast food operator Chipotle, and Meta. Picture: Elke MeitzelMunro Partners' Kieran Moore likes US Tex-Mex fast food operator Chipotle, and Meta. Picture: Elke MeitzelMunro Partners' Kieran Moore likes US Tex-Mex fast food operator Chipotle, and Meta. Picture: Elke MeitzelMunro Partners' Kieran Moore likes US Tex-Mex fast food operator Chipotle, and Meta. Picture: Elke Meitzel
February 15, 2024

Hedge fund Munro says Nvidia, Microsoft have more to run

Kieran Moore is portfolio manager of Munro Partners Global Growth Fund. The Melbourne-based hedge fund oversees $4.3 billion in assets.

Read More
January 24, 2024

How To Master The Art Of Winning The Room

Jonathan Pease, the creative director behind the Sohn Hearts & Minds Conference and author of the book, Winning the Room, recently sat down for a chat with Mark Bouris on Straight Talk.

Read More
2023’s winners: DigitalX’s Lisa Wade, Jason Orthman from Hyperion, Regal Partner’s Todd Guyot, and Cathie Wood of ARK Investment. 2023’s winners: DigitalX’s Lisa Wade, Jason Orthman from Hyperion, Regal Partner’s Todd Guyot, and Cathie Wood of ARK Investment. 2023’s winners: DigitalX’s Lisa Wade, Jason Orthman from Hyperion, Regal Partner’s Todd Guyot, and Cathie Wood of ARK Investment. 2023’s winners: DigitalX’s Lisa Wade, Jason Orthman from Hyperion, Regal Partner’s Todd Guyot, and Cathie Wood of ARK Investment. 
January 19, 2024

Best funds of 2023 stick with bitcoin, big tech bets

Some of the best performing funds of 2023 are holding firm on bitcoin and mega-cap tech stock picks that made them big money last year.

Read More
November 19, 2023

Equity Mates review the stocks pitched at the Sohn Hearts & Minds Conference

Bryce and Ren of Equity Mates attended the Sohn Hearts & Minds Conference and reviewed the stocks pitched by our new 2023 Conference Fund Managers.

Read More
Ark Invest CEO Cathie Wood remains as big-picture as ever. Picture: David RoweArk Invest CEO Cathie Wood remains as big-picture as ever. Picture: David RoweArk Invest CEO Cathie Wood remains as big-picture as ever. Picture: David RoweArk Invest CEO Cathie Wood remains as big-picture as ever. Picture: David Rowe
November 17, 2023

‘I Know It Sounds Crazy’: Cathie Wood’s Next Big Idea

Speaking from Ark’s headquarters in Florida ahead of her appearance at the Sohn Hearts & Minds Conference on Friday, Wood says she believes disinflation is now just around the corner in the US.

Read More
ARK Invest founder Cathie Wood: It does appear that the SEC here in the United States is likely to approve a spot bitcoin ETF within the next few months.ARK Invest founder Cathie Wood: It does appear that the SEC here in the United States is likely to approve a spot bitcoin ETF within the next few months.ARK Invest founder Cathie Wood: It does appear that the SEC here in the United States is likely to approve a spot bitcoin ETF within the next few months.ARK Invest founder Cathie Wood: It does appear that the SEC here in the United States is likely to approve a spot bitcoin ETF within the next few months.
November 17, 2023

ARK Founder Wood Backs Bitcoin, Banking On Spot ETF Approval

Tech investment guru Cathie Wood is still a big believer in bitcoin, so it was fitting that she chose Grayscale Bitcoin Trust as her stock pick for the 2023 Sohn Hearts & Minds Investment Leaders Conference.

Read More
IFM Investors small cap specialist Rikki Bannan addresses the Sohn Hearts & Minds Investment Leaders Conference at Sydney Opera House. Picture: Renee NowytargerIFM Investors small cap specialist Rikki Bannan addresses the Sohn Hearts & Minds Investment Leaders Conference at Sydney Opera House. Picture: Renee NowytargerIFM Investors small cap specialist Rikki Bannan addresses the Sohn Hearts & Minds Investment Leaders Conference at Sydney Opera House. Picture: Renee NowytargerIFM Investors small cap specialist Rikki Bannan addresses the Sohn Hearts & Minds Investment Leaders Conference at Sydney Opera House. Picture: Renee Nowytarger
November 17, 2023

Hot Stocks To Ride The Next Healthcare Trends

Healthcare stocks – from sleep apnoea giant ResMed, to cancer diagnostic biotech Telix Pharmaceuticals – were recommended at the Sohn Hearts & Minds Investment Leaders Conference on Friday.

Read More
November 17, 2023

How Daniel Loeb, The Real Bobby Axelrod, Made His Wall Street Billions

When Damian Lewis, the actor who plays the ruthless hedge fund boss in the drama series Billions was looking for inspiration, he sat down with Daniel Loeb.

Read More
November 17, 2023

The 12 Hottest Stock Tips From This Year’s Sohn Experts

It might be time to look beyond big names. That was the message from top fund managers, company founders and super funds at the Sohn Hearts & Minds.

Read More
Azora Capital founder Ravi Chopra. Picture: Renee NowytargerAzora Capital founder Ravi Chopra. Picture: Renee NowytargerAzora Capital founder Ravi Chopra. Picture: Renee NowytargerAzora Capital founder Ravi Chopra. Picture: Renee Nowytarger
November 17, 2023

Webster Financial ‘Avoided The Mistakes Of US Bank Failures’

The US financial sector is not without its problems but Ravi Chopra backs Webster Financial Corporation as his stock pick for the 2023 Sohn Hearts & Minds Investment Leaders Conference.

Read More
November 17, 2023

Why Stock Picker Cathie Wood Of ARK Can’t Stand Google

The world’s highest-profile tech investor, Cathie Wood, might be bruised but she is certainly bullish. Nor is she holding back.

Read More
Munro Partners partner and portfolio manager Kieran Moore at the Sohn Hearts & Minds conference in Sydney. Picture: Renee NowytargerMunro Partners partner and portfolio manager Kieran Moore at the Sohn Hearts & Minds conference in Sydney. Picture: Renee NowytargerMunro Partners partner and portfolio manager Kieran Moore at the Sohn Hearts & Minds conference in Sydney. Picture: Renee NowytargerMunro Partners partner and portfolio manager Kieran Moore at the Sohn Hearts & Minds conference in Sydney. Picture: Renee Nowytarger
November 17, 2023

Wise Share Price Could Rise 50pc By 2025, Says Munro Partners

Global growth fund manager Munro has about $4.3bn in funds under management across four global funds, and usually invests in companies that are poised to win from massive structural change.

Read More
Martin Hughes founder of UK-based Toscafund. Picture: Elke MeitzelMartin Hughes founder of UK-based Toscafund. Picture: Elke MeitzelMartin Hughes founder of UK-based Toscafund. Picture: Elke MeitzelMartin Hughes founder of UK-based Toscafund. Picture: Elke Meitzel
November 16, 2023

Hedge Fund Veteran Talks Lowest Moment In Toscafund’s 23-Year Run

Most hedge fund managers brag about their wins and shy away from their losses – Martin Hughes is not most hedge fund managers.

Read More
November 16, 2023

The ‘Armageddon Scenario’ Worrying The Future Fund CIO

Mr Samild shared his thoughts on the bond market – which underpins the returns of other assets – ahead of his appearance at Friday’s Sohn Hearts & Minds charity conference at the Sydney Opera House.

Read More
Daniel MacArthur with Melbourne scientist and assistant professor Misty Jenkins. Both will be speaking at the Sohn Hearts & Minds conference in Sydney.Daniel MacArthur with Melbourne scientist and assistant professor Misty Jenkins. Both will be speaking at the Sohn Hearts & Minds conference in Sydney.Daniel MacArthur with Melbourne scientist and assistant professor Misty Jenkins. Both will be speaking at the Sohn Hearts & Minds conference in Sydney.Daniel MacArthur with Melbourne scientist and assistant professor Misty Jenkins. Both will be speaking at the Sohn Hearts & Minds conference in Sydney.
November 15, 2023

Advancing Medicine Is In Daniel MacArthur’s DNA

When genomic scientist Daniel MacArthur had the opportunity to set up a new Centre for Population Genomics in Australia in 2019, he jumped at the chance to return home after 12 years living overseas.

Read More
November 15, 2023

Ashish Swarup - Invest In Snacks, Let's Get That Bread | Aikya Investment Management

Ashish Swarup, Portfolio Manager and Investment Analyst of Aikya Investment Management joins Bryce and Ren to discuss emerging markets, and two stock deep dives.

Read More
Surging interest rates have delivered new investment opportunities for Wall Street hedge fund Third Point. Picture: Getty Images/AFPSurging interest rates have delivered new investment opportunities for Wall Street hedge fund Third Point. Picture: Getty Images/AFPSurging interest rates have delivered new investment opportunities for Wall Street hedge fund Third Point. Picture: Getty Images/AFPSurging interest rates have delivered new investment opportunities for Wall Street hedge fund Third Point. Picture: Getty Images/AFP
November 15, 2023

Daniel Loeb’s Wall St Hedge Fund Third Point Raises Bets On Corporate Credit Crunch

An “obsession” around balance sheet strength and debt is creating a new wave of investment bets for the influential Wall Street hedge fund run by Daniel Loeb.

Read More
November 13, 2023

Bond Bullish On Commodity Stocks, Uranium

Mining stocks are poised to rise amid tight supply for key commodities such as copper, nickel and uranium, says Terra Capital founder Jeremy Bond.

Read More
November 13, 2023

This Hedge Fund Manager Is Making A 100-Year Bet On Luxury

European leisure and luxury – a designer handbag, a last-minute flight to Monte Carlo, a stay in a five-star hotel – is where many choose to spend their hard-earned cash. For Sharif el Khazen, it’s where he makes it.

Read More
Munro partner and portfolio manager Kieran Moore says Nvidia will be critical in the expansion of accelerated computing. Picture: NCANewswire / Nicki ConnollyMunro partner and portfolio manager Kieran Moore says Nvidia will be critical in the expansion of accelerated computing. Picture: NCANewswire / Nicki ConnollyMunro partner and portfolio manager Kieran Moore says Nvidia will be critical in the expansion of accelerated computing. Picture: NCANewswire / Nicki ConnollyMunro partner and portfolio manager Kieran Moore says Nvidia will be critical in the expansion of accelerated computing. Picture: NCANewswire / Nicki Connolly
November 12, 2023

How Munro Will Pick Its Next Stock Winner

Munro partner and portfolio manager Kieran Moore must select a single company to pitch to an audience of industry heavyweights at the prestigious Sohn Hearts & Minds conference in Sydney.

Read More
Ray Dalio last month. His hedge fund has been under heightened scrutiny with the release of a tell-all book. Picture: BloombergRay Dalio last month. His hedge fund has been under heightened scrutiny with the release of a tell-all book. Picture: BloombergRay Dalio last month. His hedge fund has been under heightened scrutiny with the release of a tell-all book. Picture: BloombergRay Dalio last month. His hedge fund has been under heightened scrutiny with the release of a tell-all book. Picture: Bloomberg
November 12, 2023

The Australian At The Centre Of Dalio’s Bridgewater – Who Loves It

The culture at Ray Dalio’s massive hedge fund has been a source of intrigue, and with a new book, controversy. Atul Lele says it’s made him a better investor.

Read More
Sheila Patel has had an extraordinary career across Goldman Sachs and now the VC sector. Picture: Dominic LorrimerSheila Patel has had an extraordinary career across Goldman Sachs and now the VC sector. Picture: Dominic LorrimerSheila Patel has had an extraordinary career across Goldman Sachs and now the VC sector. Picture: Dominic LorrimerSheila Patel has had an extraordinary career across Goldman Sachs and now the VC sector. Picture: Dominic Lorrimer
November 10, 2023

Meet The Goldman Sachs Legend Shaking Up Venture Capital

Sheila Patel says it was time for the venture capital sector to “grow up” and higher rates will help do that job. VC firms need to think differently about how they invest.

Read More
November 8, 2023

Tom Naughton - There's Money In Mi Goreng | Prusik Investment

Tom Naughton is Managing Partner and CIO at Prusik Investment. In this episode, he chats to Equity Mates ahead of his appearance at the 2023 Sohn Hearts and Minds Conference.

Read More
November 6, 2023

Why Chris Kourtis just bought CSL and ResMed

A true contrarian investor, Chris Kourtis can find himself sounding a lot like a bull when in the company of bears, and there’s a lot to be bearish about at the moment.

Read More
Jun Bei Liu being coached by Jonathan Pease. Picture: Renee Nowytarger.Jun Bei Liu being coached by Jonathan Pease. Picture: Renee Nowytarger.Jun Bei Liu being coached by Jonathan Pease. Picture: Renee Nowytarger.Jun Bei Liu being coached by Jonathan Pease. Picture: Renee Nowytarger.
November 5, 2023

Five Secrets To Delivering The Perfect Pitch

Australia’s best stock pickers have just eight minutes to convince the country’s top money managers they have found an investment gem that the market has overlooked.

Read More
Picture: Solomon Lew & David ParadicePicture: Solomon Lew & David ParadicePicture: Solomon Lew & David ParadicePicture: Solomon Lew & David Paradice
November 3, 2023

Paradice and Lew on their love of medical research – and Greece

Solomon Lew, the billionaire retailer, has known David Paradice, the high-profile fund managers, for years. Beyond investing, they share a common interest in medical research – and holidaying in Greece.

Read More
November 2, 2023

Meet the 2023 Conference Managers

Following a rigorous global search, the Conference Fund Manager Selection Committee is pleased to share ten new managers for 2023.

Read More
Daniel Loeb oversees $US11.7 billion ($18.5 billion) at New York-based Third Point. Picture: BloombergDaniel Loeb oversees $US11.7 billion ($18.5 billion) at New York-based Third Point. Picture: BloombergDaniel Loeb oversees $US11.7 billion ($18.5 billion) at New York-based Third Point. Picture: BloombergDaniel Loeb oversees $US11.7 billion ($18.5 billion) at New York-based Third Point. Picture: Bloomberg
October 23, 2023

Dan Loeb to headline Sohn Hearts & Minds

Famed hedge fund manager Dan Loeb has been named as one of the headline acts for next month’s Sohn Hearts & Minds philanthropic investment conference to be held in Sydney.

Read More
Ravi Chopra's Azora Capital had its best month in March when it shorted the US banks that failed. Picture: Jaclyn LichtRavi Chopra's Azora Capital had its best month in March when it shorted the US banks that failed. Picture: Jaclyn LichtRavi Chopra's Azora Capital had its best month in March when it shorted the US banks that failed. Picture: Jaclyn LichtRavi Chopra's Azora Capital had its best month in March when it shorted the US banks that failed. Picture: Jaclyn Licht
October 23, 2023

US Bank Run Has Slowed To A Walk, But Instability Remains

When Ravi Chopra reveals his stock pick at the prestigious Sohn Hearts & Minds conference at the Opera House in Sydney next month, it could well be a short bet on a US bank.

Read More
October 18, 2023

Two small caps: Propel Funeral Services (ASX: PFP) and Clarity Pharmaceuticals (ASX: CU6)

Get to know our 2023 Conference Fund Manager Rikki Bannan of IFM Investors who recently featured on the Equity Mates Media podcast.

Read More
October 16, 2023

How this hedge fund pulled off 2023’s ‘big short’

Last year, Ravi Chopra was travelling through Europe to shop his latest short idea to potential investors. “Financials are really all in the weeds,” he told The Australian Financial Review in an interview from New York.

Read More
IFM Investors executive director Rikki Bannan is a keen follower of stocks in the healthcare sector, but she knows it can be a risky place to invest.IFM Investors executive director Rikki Bannan is a keen follower of stocks in the healthcare sector, but she knows it can be a risky place to invest.IFM Investors executive director Rikki Bannan is a keen follower of stocks in the healthcare sector, but she knows it can be a risky place to invest.IFM Investors executive director Rikki Bannan is a keen follower of stocks in the healthcare sector, but she knows it can be a risky place to invest.
October 10, 2023

Beware the pitfalls of investing in healthcare, says IFM boss

“Healthcare is often viewed as a stable, defensive sector to invest in, but in small caps that hasn’t necessarily proven to be the case,” she says in an interview ahead of her appearance at the Sohn Hearts & Minds Conference 2023.

Read More
Angela Aldrich of Bayberry Capital Partners in New York. Picture: Jaclyn Licht.Angela Aldrich of Bayberry Capital Partners in New York. Picture: Jaclyn Licht.Angela Aldrich of Bayberry Capital Partners in New York. Picture: Jaclyn Licht.Angela Aldrich of Bayberry Capital Partners in New York. Picture: Jaclyn Licht.
September 18, 2023

‘Volatility is opportunity’: why this manager loves shorting stocks

Angela Aldrich of Bayberry Capital Partners LP bet against Treasury Wine Estates at the top of the market and now she's preparing to make her next big call at this year's Sohn Hearts & Minds Conference.

Read More
September 15, 2023

Top fund managers share 11 stock picks for the long term

After a dramatic earnings season, fund managers, including Jessica Farr-Jones of Regal Funds and Kieran Moore of Munro Partners (HM1 Core Fund Managers), have shared some of their top picks for long-term growth.

Read More
September 11, 2023

Investors Sweeten On Hedge Funds As Rates Climb

After a decade of easy money pushing equity markets in one direction, Wall Street hedge fund manager Ricky Sandler says the return of volatility and higher interest rates is seeing money return to long-short strategies.

Read More
Eminence Capital CEO Ricky Sandler, left, with Sohn Australia co-founder Matthew Grounds. Picture: John FederEminence Capital CEO Ricky Sandler, left, with Sohn Australia co-founder Matthew Grounds. Picture: John FederEminence Capital CEO Ricky Sandler, left, with Sohn Australia co-founder Matthew Grounds. Picture: John FederEminence Capital CEO Ricky Sandler, left, with Sohn Australia co-founder Matthew Grounds. Picture: John Feder
September 11, 2023

Stock Stars Look Under The Surface

Influential New York-hedge fund manager Ricky Sandler returns to Australia to make a new pick at this year’s Sohn Hearts & Minds conference that will be held at the Sydney Opera House on November 17.

Read More
Barrenjoey co-executive chairman Matthew Grounds and New York-based Eminence Capital fund manager Ricky Sandler will be at the eighth Sohn Hearts & Minds conference. Picture: Peter RaeBarrenjoey co-executive chairman Matthew Grounds and New York-based Eminence Capital fund manager Ricky Sandler will be at the eighth Sohn Hearts & Minds conference. Picture: Peter RaeBarrenjoey co-executive chairman Matthew Grounds and New York-based Eminence Capital fund manager Ricky Sandler will be at the eighth Sohn Hearts & Minds conference. Picture: Peter RaeBarrenjoey co-executive chairman Matthew Grounds and New York-based Eminence Capital fund manager Ricky Sandler will be at the eighth Sohn Hearts & Minds conference. Picture: Peter Rae
September 11, 2023

Top Ny Stock Picker Warns Inflation To Remain Above Pre-Covid Levels

Influential New York hedge fund manager Ricky Sandler of Eminence Capital returns for the 2023 Sohn Hearts & Minds Conference in Sydney and says no one is focused on picking interesting, idiosyncratic stocks.

Read More
August 4, 2023

New Relic

New Relic was pitched by Ricky Sandler of Eminence Capital at the 2022 Sohn Hearts & Minds Conference.

Read More
June 18, 2023

Investors can’t agree how to value the world’s hottest stock

Despite mixed investor opinions, Munro Partners (Core Fund Manager) remains a strong believer in Nvidia. They are standing firm in their investment and still consider it a solid buy.

Read More
June 8, 2023

Stock pickers bet the field in slowing domestic market

Fund managers have batted away fears of an inflation-led recession, with Qantas, Seven Group and Treasury Wines named among the best investments by Australia’s top stock pickers.

Read More
March 27, 2023

The imaginary nepotism that drives Carsales global growth

The long-term approach of Carsales (2022 Conference stock pick) and its CEO Cameron McIntyre has delivered big gains for investors. He reveals his secret to staying strategic.

Read More
December 10, 2024

Professor Jane Butler: Sparking Hope for Spinal Cord Injuries

In this episode of the Hearts & Minds Podcast, we sit down with Professor Jane Butler to discuss her groundbreaking research into spinal cord injuries.

Read More
impact-podcasts
September 24, 2024

Asian Market Potential with Tom Naughton of Prusik

CIO Charlie Lanchester sits down with Tom Naughton, CIO of Prusik Investment Mgmt. Tom shares his investment philosophy, the opportunities and challenges in Asian markets, and how his 2023 conference stock pick, Swire Pacific (0019.HK), delivered an impressive 30% return.

Read More
investing
September 4, 2024

Building Hearts and Minds with Co-Founders Matthew Grounds and Guy Fowler

In this episode, co-founders Matthew Grounds AM and Guy Fowler OAM discuss their journey in building Hearts & Minds and its philanthropic model that has donated over $70 million to medical research.

Read More
investing
June 25, 2024

Navigating the Resource Sector with Jeremy Bond of Terra Capital

In this episode, we chat with Jeremy Bond, Founder of Terra Capital and HM1 Conference Fund Manager. Tune in for insights into the world of resource investments and the exciting opportunities that lie ahead.

Read More
investing
June 11, 2024

Prof. Nadia Badawi on Cerebral Palsy Breakthroughs and Neonatal Care

Dive deep into the groundbreaking work of Professor Nadia Badawi, an internationally recognised neonatologist and expert in Cerebral Palsy.

Read More
impact-podcasts
May 28, 2024

Investment Insights: Rikki Bannan on Top Picks and Trends

Join us for an engaging episode featuring Rikki Bannan, Portfolio Manager of IFM Investors and HM1 Conference Fund Manager. This episode explores Rikki's career journey, investment strategies, and her 2023 conference stock pick, Telix Pharmaceuticals (ASX.TLX).

Read More
investing
December 6, 2023

Peter Cooper talks building and instilling a culture of humility and excellence

In this episode, our guest is the renowned investor, Peter Cooper, founder and Chief Investment Officer of Cooper Investors (Core Fund Manager). A founding supporter of Hearts and Minds, Peter is a staunch advocate of our model and its philanthropic purpose, actively engaging in every facet of Hearts and Minds.

Read More
investing
November 28, 2023

Jun Bei Liu on her high conviction investment strategy

In this episode, HM1 Chief Investment Officer Charlie Lanchester is joined by Jun Bei Liu. Jun Bei is the Portfolio Manager of Tribeca’s Alpha Plus Fund and since taking over managing the Fund, she has quadrupled AUM.

Read More
investing
November 21, 2023

The world of rare genetic disease research

In this episode, we speak to Associate Professor Gina Ravenscroft. Gina is an Associate Professor in Neurogenetics at the Harry Perkins Institute of Medical Research in Perth. Her research interests are in rare genetic diseases, with a particular focus on neurogenetic diseases in babies and children.

Read More
impact-podcasts
November 14, 2023

Learn what makes a high conviction investment and how to avoid short-term noise

In this episode, our Core Fund Manager Magellan shares how they select top stocks for the HM1 portfolio.

Read More
investing
November 7, 2023

Delve into the world of kids critical care and trauma research

In thie episode, we are joined by Dr. Marino Festa, or Rino for short. He is the Medical Director of NSW Kids ECMO Referral Service and a senior specialist in Paediatric Intensive Care at Children’s Hospital at Westmead.

Read More
impact-podcasts
October 31, 2023

Where Regal's Phil King is searching for opportunities

HM1's CIO, Charlie Lanchester, talks to Phil King of Regal Funds about his passion for stocks, his ongoing search for opportunities, and some of the sectors he’s excited by right now. Phil King of Regal Funds, has been a tremendous supporter of Hearts & Minds since the beginning.

Read More
investing
October 24, 2023

Preventing recurrent miscarriages and birth defects

In this episode, CEO Paul Rayson is joined by renowned biomedical researcher Professor Sally Dunwoodie. Prof. Dunwoodie's groundbreaking work has revolutionised clinical practices and enabled genetic diagnostic tests worldwide. In 2017, her team achieved a double breakthrough with the potential to prevent recurrent miscarriages and various birth defects.

Read More
impact-podcasts
October 17, 2023

Nick Griffin on how he finds global winners

In this episode, CIO Charlie Lanchester chats with Nick Griffin, the founding partner and CIO of Munro Partners, one of HM1's Core Fund Managers. They go over his career to date, reflect on the lessons he’s learned, and trace the decisions that led to him starting Munro.

Read More
investing
October 10, 2023

How A/Prof Matt Call is teaching our body to kill cancer

In this episode, CEO Paul Rayson is joined by WEHI’s Associate Professor Matt Call to talk about his incredible research. Matt’s team teaches and trains the body's own immune cells to target and kill cancer cells.

Read More
impact-podcasts